*Kazutaka Ohi1,2, Mihoko Shimada3, Midori Soda4, Daisuke Nishizawa5, Daisuke Fujikane1, Kentaro Takai1, Ayumi Kuramitsu1, Yukimasa Muto1, Shunsuke Sugiyama1, Junko Hasegawa5, Kiyoyuki Kitaichi4, Kazutaka Ikeda5, Toshiki Shioiri1 (1. Department of Psychiatry, Gifu University Graduate School of Medicine, 2. Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan, 3. Genome Medical Science Project (Toyama), National Center for Global Health and Medicine (NCGM), Tokyo, Japan, 4. Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan, 5. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)
Session information
Poster
F. Basic and Clinical Science of Mental Disorders
[3P] 62 Schizophrenia
Fri. Jul 26, 2024 1:50 PM - 2:50 PM Poster Room (Marine Messe Fukuoka Hall B)
*Shoko Shimizu1, Yugo Ishino1, Shingo Miyata1 (1. Research Institute of Traditional Asian Medicine, Kindai Univ, Osaka, Japan)
[3P-248] Alterations in inhibitory neurons caused by 3q29 deletion with high risk for schizophrenia.
Presentation at Industrial-Academic Collaboration
*Takuto Matsuda1, Yuko Arioka2,3, Hiroki Okumura2,4, Daisuke Mori2,5, Norio Ozaki2 (1. Psychiatry, Grad Sch Med, Nagoya Univ, Nagoya, Japan, 2. Pathophysiology of Mental Disorders, Grad Sch Med, Nagoya Univ, Nagoya, Japan, 3. Center for Advanced Medicine and Clinical Research, Nagoya Univ Hospital, 4. Department of Hospital Pharmacy, Nagoya Univ Hospital, 5. Brain & Mind Research Center, Nagoya Univ, Nagoya, Japan)
*Ayumu Kawasaki1, Takumi Nakamuara1, Hirotaka Shoji3, Hirona Yamamoto1, Kurara Honda1, Tsuyoshi Miyakawa3, Nobuya Sasaki2, Atsushi Takata1 (1. RIKEN Center for Brain Science, 2. School of Veterinary Medicine, Kitasato University, 3. Center for Medical Science, Fujita Health University)